Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?

Published on November 16, 2022

Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.

Continue reading on website
Other news

The Fed WANTS a Bear Market & Recession

November 16, 2022
The stock market (SPY) rally since Thursday’s better than expected CPI report has been impressive. And on the surface, it only seems to be bolstered by Tuesdays PPI report. Unfortunately,...

Want Your Employees Back in the Office? Here's How to Make It a Place They Want to Be.

November 16, 2022
Before your call back to the office is met with groans and criticism, consider these strategies to meet the needs of your employees and foster a more productive work environment.